Atlas Trials

The Evaluation of Safety and Tolerance of Commercially Available Naltrexone Administered Daily - Assessment for CBRN Operations

Clinical trial NCT03879460 · COMPLETED

Trial details

NCT number
NCT03879460
Sponsor
Timothy Smith
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Opioid Intoxication
Start date
2019-03-18
Primary completion
2019-03-31
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.